Researcher.Life Logo

Clinical Proteomics : Impact Factor & More

eISSN: 1559-0275pISSN: 1542-6416
JournalOpen Access

Aims and Scope of Clinical Proteomics

Clinical Proteomics is a peer-reviewed open access medical journal published by BioMed Central. Covers scientific research in the field of translational proteomics with an emphasis on the application of proteomic technology to all aspects of clinical research. It was established in March 2004 and the editor in chief is Daniel W. Chan (Johns Hopkins School of Medicine). Less

Key Metrics

CiteScore
7.1
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Molecular Biology
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical Proteomics

Clinical Proteomics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2090 | USD 2490 | GBP 1790
Publication Time17
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2004
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 17
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Clinical Proteomics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Proteomics

N-glycomics profiling reveals alteration of fucosylation in early acute ischemic stroke from mouse brain tissue to human serum.
  • 28 Jan 2026
  • Clinical proteomics
Comprehensive analysis of proteomics and lactylation proteomics in ovarian granulosa cells of patients with polycystic ovary syndrome.
  • 24 Jan 2026
  • Clinical proteomics
ProteoBoostR: an interactive framework for supervised machine learning in clinical proteomics
  • 24 Jan 2026
  • Clinical Proteomics
Plasma proteomic profiling reveals distinct protein signatures associated with hepatocellular carcinoma in chronic hepatitis B infection.
  • 17 Jan 2026
  • Clinical proteomics
Tetraspanin-based immunocapture for high-depth proteomic profiling of extracellular vesicles from cerebrospinal fluid for biomarker discovery.
  • 17 Jan 2026
  • Clinical proteomics
Integrating human plasma proteomes with genome-wide association data implicates novel proteins and drug targets for rheumatoid arthritis.
  • 15 Jan 2026
  • Clinical proteomics
N-glycomics profiling reveals alteration of fucosylation in early acute ischemic stroke from mouse brain tissue to human serum.
  • 28 Jan 2026
  • Clinical proteomics
Comprehensive analysis of proteomics and lactylation proteomics in ovarian granulosa cells of patients with polycystic ovary syndrome.
  • 24 Jan 2026
  • Clinical proteomics
ProteoBoostR: an interactive framework for supervised machine learning in clinical proteomics
  • 24 Jan 2026
  • Clinical Proteomics
Plasma proteomic profiling reveals distinct protein signatures associated with hepatocellular carcinoma in chronic hepatitis B infection.
  • 17 Jan 2026
  • Clinical proteomics
Tetraspanin-based immunocapture for high-depth proteomic profiling of extracellular vesicles from cerebrospinal fluid for biomarker discovery.
  • 17 Jan 2026
  • Clinical proteomics
Integrating human plasma proteomes with genome-wide association data implicates novel proteins and drug targets for rheumatoid arthritis.
  • 15 Jan 2026
  • Clinical proteomics

FAQs on Clinical Proteomics